SCHEMBL562764

SCHEMBL562764

C=CCC(=O)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL6078515 0.97
SCHEMBL27509208 0.97
SCHEMBL9569154 0.87 OR51E2 (0.32)
SCHEMBL14993495 0.83 TSHR (0.39)
SCHEMBL2019340 0.83 TSHR (0.38)
SCHEMBL11801792 0.80 ALOX15 (0.34)
SCHEMBL20505388 0.78 ALDH1A1 (0.41)
SCHEMBL7219664 0.78 HAO1 (0.39)
SCHEMBL6448688 0.77
SCHEMBL815174 0.75 LMNA (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 327 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072741-A1 PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2025-04-03 WO claimed
WO-2023091990-A1 COMPOSITIONS AND METHODS TARGETING GABA SIGNALING PATHWAY FOR SOLID TUMOR CANCER TREATMENT DUKE UNIVERSITY (US) 2023-05-25 WO claimed
US-10669561-B2 Microorganisms for producing 4C-5C compounds with unsaturation and methods related thereto GENOMATICA, INC. (US) 2020-06-02 US claimed
US-20160355843-A1 METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE INVISTA NORTH AMERICA S.A.R.L. (US) 2016-12-08 US claimed
US-20160355844-A1 METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE INVISTA NORTH AMERICA S.A.R.L. (US) 2016-12-08 US claimed
EP-1700922-B1 3-Substituted 5-Nitroindole derivatives and labeled oligonucleotide probes containing them ROCHE DIAGNOSTICS GMBH (DE) 2016-08-24 EP claimed
EP-2861745-A2 METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE Invista Technologies S.à.r.l. (CH) 2015-04-22 EP claimed
EP-2785848-A2 METHODS FOR BIOSYNTHESIZING 1,3BUTADIENE INVISTA Technologies S.à.r.l. (CH) 2014-10-08 EP claimed
US-20140141482-A1 METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE INVISTA North America S.á r.l. (US) 2014-05-22 US claimed
WO-2013188546-A2 METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE INVISTA TECHNOLOGIES S.À.R.L. (CH) 2013-12-19 WO claimed
WO-2000035858-A1 PHENYLGLYCINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2000-06-22 WO claimed
WO-2000004892-A2 COADMINISTRATION OF ACAT AND MMP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROTIC LESIONS WARNER-LAMBERT COMPANY (US) 2000-02-03 WO claimed
WO-1999047138-A1 STATIN-MATRIX METALLOPROTEINASE INHIBITOR COMBINATIONS WARNER-LAMBERT COMPANY (US) 1999-09-23 WO claimed
US-5948780-A ADMINISTERING A METALLOPROTEINASE INHIBITOR WARNER-LAMBERT COMPANY (US) 1999-09-07 US claimed
WO-1999032150-A1 ACE INHIBITOR-MMP INHIBITOR COMBINATIONS WARNER-LAMBERT COMPANY (US) 1999-07-01 WO claimed
WO-1998025597-A2 METHOD FOR TREATING AND PREVENTING HEART FAILURE AND VENTRICULAR DILATATION WARNER-LAMBERT COMPANY (US) 1998-06-18 WO claimed
EP-0816429-A2 Self-curing aqueous dispersions of polyesters and vinyl polymers Vianova Resins GmbH (DE) 1998-01-07 EP claimed
EP-0593452-A1 METHOD FOR PREPARING A METAL-RADIONUCLIDE-LABELLED PROTEIN MALLINCKRODT MEDICAL, INC. (US) 1994-04-27 EP claimed
EP-0593452-A4 METHOD FOR PREPARING A METAL-RADIONUCLIDE-LABELLED PROTEIN. MALLINCKRODT MEDICAL INC (US) 1992-08-31 EP claimed
WO-1991007991-A1 METHOD FOR PREPARING A METAL-RADIONUCLIDE-LABELLED PROTEIN MALLINCKRODT MEDICAL, INC. (US) 1991-06-13 WO claimed